Kenneth R. Fisher - 23 Mar 2022 Form 4 Insider Report for Bluejay Diagnostics, Inc. (BJDX)

Role
Chief Financial Officer
Signature
/s/ Kenneth Fisher
Issuer symbol
BJDX
Transactions as of
23 Mar 2022
Net transactions value
$0
Form type
4
Filing time
28 Mar 2022, 14:57:30 UTC
Previous filing
15 Nov 2021
Next filing
27 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BJDX Option (right to buy) Award +65,000 65,000 23 Mar 2022 Common Stock 65,000 $1.31 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Of the option grant, 5,000 shares were fully-vested on the Transaction Date and 60,000 shares will vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.
F2 Issued in connection with the reporting person's employment with the Company.